O

Ondine Biomedical Inc
LSE:OBI

Watchlist Manager
Ondine Biomedical Inc
LSE:OBI
Watchlist
Price: 8.65 GBX 1.76%
Market Cap: 34.9m GBX
Have any thoughts about
Ondine Biomedical Inc?
Write Note

Wall Street
Price Targets

OBI Price Targets Summary
Ondine Biomedical Inc

There are no price targets for OBI.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Ondine Biomedical Inc Competitors:
Price Targets
NPCE
Neuropace Inc
45% Upside
PEN
Penumbra Inc
10% Upside
PRN
Profound Medical Corp
111% Upside
099190
I Sens Inc
90% Upside
STIL
Stille AB
28% Upside
VREX
Varex Imaging Corp
50% Upside
MASI
Masimo Corp
6% Upside
688677
Qingdao NovelBeam Technology Co Ltd
73% Upside

Revenue
Forecast

Revenue Estimate
Ondine Biomedical Inc

For the last 13 years the compound annual growth rate for Ondine Biomedical Inc's revenue is 8%. The projected CAGR for the next 4 years is 136%.

8%
Past Growth
136%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Ondine Biomedical Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Ondine Biomedical Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OBI's stock price target?
Not Available

OBI doesn't have any price targets made by Wall Street professionals.

What is Ondine Biomedical Inc's Revenue forecast?
Projected CAGR
136%

For the last 13 years the compound annual growth rate for Ondine Biomedical Inc's revenue is 8%. The projected CAGR for the next 4 years is 136%.

Back to Top